Showing results (1561-1570 of 1,790) with videos related to
Sort By:
Pageof 179
Journal of Cardiovascular Pharmacology|August 13, 1998
Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802S A Mousa, R E Olson, J M Bozarth, et al.Journal of Neuroinflammation|November 20, 2021
CD4+ effector T cells accelerate Alzheimer's disease in miceJatin Machhi, Pravin Yeapuri, Yaman Lu, et al.Annals of Neurology|January 31, 2017
Genetics and genotype-phenotype correlations in early onset epileptic encephalopathy with burst suppressionHeather E Olson, McKenna Kelly, Christopher M LaCoursiere, et al.Bioorganic & Medicinal Chemistry Letters|February 14, 2006
Synthesis and evaluation of succinoyl-caprolactam gamma-secretase inhibitorsLorin A Thompson, Ann Y Liauw, Mercy M Ramanjulu, et al.NPJ Parkinson'S Disease|June 27, 2017
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trialHoward E Gendelman, Yuning Zhang, Pamela Santamaria, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 23, 2016
Multidisciplinary model to implement pharmacogenomics at the point of carePedro J Caraballo, Lucy S Hodge, Suzette J Bielinski, et al.Bioorganic & Medicinal Chemistry Letters|December 7, 2002
Imidazo[4,5-b]pyridines as corticotropin releasing factor receptor ligandsArgyrios G Arvanitis, Joseph T Rescinito, Charles R Arnold, et al.Population Health Metrics|September 23, 2021
Effect of birthweight measurement quality improvement on low birthweight prevalence in rural EthiopiaEstifanos Baye, Firehiwot Workneh Abate, Michelle Eglovitch, et al.Bioorganic & Medicinal Chemistry Letters|February 8, 2017
Design and synthesis of a novel series of 4-heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes as α7 nicotinic receptor agonists 2. Development of 4-heteroaryl SARChristiana Iwuagwu, Dalton King, Ivar M McDonald, et al.Bioorganic & Medicinal Chemistry Letters|October 23, 2012
4-Phenyl tetrahydroisoquinolines as dual norepinephrine and dopamine reuptake inhibitorsAnthony D Pechulis, James P Beck, Matt A Curry, et al.Pageof 179